These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 23454054

  • 21. Effect of melt sonocrystallization on pharmacotechnical properties of paracetamol, indomethacin and mefenamic acid characterized by dynamic laser scattering and its impact on solubility.
    Kumar B, Sharma V, Pathak K.
    Drug Dev Ind Pharm; 2013 May; 39(5):687-95. PubMed ID: 22630048
    [Abstract] [Full Text] [Related]

  • 22. Enhanced release of indomethacin from Pvp/stearic acid microcapsules prepared coupling Co-freeze-drying and ultrasound assisted spray-congealing process.
    Cavallari C, Luppi B, Di Pietra AM, Rodriguez L, Fini A.
    Pharm Res; 2007 Mar; 24(3):521-9. PubMed ID: 17252191
    [Abstract] [Full Text] [Related]

  • 23. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX, Anderson BD.
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [Abstract] [Full Text] [Related]

  • 24. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability.
    Wu JX, Yang M, Berg Fv, Pajander J, Rades T, Rantanen J.
    Eur J Pharm Sci; 2011 Dec 18; 44(5):610-20. PubMed ID: 22024381
    [Abstract] [Full Text] [Related]

  • 25. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK, Shah SA.
    Pharm Dev Technol; 2013 Dec 18; 18(2):443-53. PubMed ID: 22686294
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T, Otsuka M.
    Pharm Res; 2005 Aug 18; 22(8):1350-7. PubMed ID: 16078145
    [Abstract] [Full Text] [Related]

  • 27. Clarification of the Dissolution Mechanism of an Indomethacin/Saccharin/Polyvinylpyrrolidone Ternary Solid Dispersion by NMR Spectroscopy.
    Kosaka M, Higashi K, Nishimura M, Ueda K, Moribe K.
    J Pharm Sci; 2020 Dec 18; 109(12):3617-3624. PubMed ID: 32931779
    [Abstract] [Full Text] [Related]

  • 28. Effect of protective colloids on the induction of polymorphic changes in indomethacin agglomerates after solvent evaporation from o/w emulsions.
    Lin SY, Chen KS, Teng HS.
    J Microencapsul; 1999 Dec 18; 16(1):39-47. PubMed ID: 9972501
    [Abstract] [Full Text] [Related]

  • 29. Triboelectrification and dissolution property enhancements of solid dispersions.
    Asare-Addo K, Šupuk E, Al-Hamidi H, Owusu-Ware S, Nokhodchi A, Conway BR.
    Int J Pharm; 2015 May 15; 485(1-2):306-16. PubMed ID: 25772415
    [Abstract] [Full Text] [Related]

  • 30. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
    Hédoux A, Paccou L, Guinet Y, Willart JF, Descamps M.
    Eur J Pharm Sci; 2009 Sep 10; 38(2):156-64. PubMed ID: 19591926
    [Abstract] [Full Text] [Related]

  • 31. Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.
    Bookwala M, Thipsay P, Ross S, Zhang F, Bandari S, Repka MA.
    Eur J Pharm Biopharm; 2018 Oct 10; 131():109-119. PubMed ID: 30086393
    [Abstract] [Full Text] [Related]

  • 32. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P, Benkic P, Smrkolj M, Vrecer F.
    Pharmazie; 2016 May 10; 71(5):263-8. PubMed ID: 27348970
    [Abstract] [Full Text] [Related]

  • 33. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov 10; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 34. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H, Iwata M, Ito M, Noguchi S.
    Mol Pharm; 2021 Sep 06; 18(9):3475-3483. PubMed ID: 34372659
    [Abstract] [Full Text] [Related]

  • 35. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW, Löbmann K, Grohganz H, Rades T, Chieng N.
    J Pharm Pharmacol; 2016 Jan 06; 68(1):36-45. PubMed ID: 26663364
    [Abstract] [Full Text] [Related]

  • 36. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
    Shi X, Song S, Ding Z, Fan B, Huang W, Xu T.
    J Pharm Sci; 2019 Sep 06; 108(9):3020-3028. PubMed ID: 31067482
    [Abstract] [Full Text] [Related]

  • 37. Solubility and stability of indomethacin in arginine-assisted solubilization system.
    Qi X, Zhang J, Wang W, Cao D.
    Pharm Dev Technol; 2013 Sep 06; 18(4):852-5. PubMed ID: 21749269
    [Abstract] [Full Text] [Related]

  • 38. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
    Lin HL, Zhang GC, Huang YT, Lin SY.
    J Pharm Sci; 2014 Aug 06; 103(8):2386-95. PubMed ID: 24942554
    [Abstract] [Full Text] [Related]

  • 39. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
    Otsuka M, Kato F, Matsuda Y, Ozaki Y.
    AAPS PharmSciTech; 2003 Aug 06; 4(2):E19. PubMed ID: 12916901
    [Abstract] [Full Text] [Related]

  • 40. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA, Laitinen R, Grohganz H, Rades T, Strachan CJ.
    Eur J Pharm Biopharm; 2013 Nov 06; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.